Hubei Jumpcan Pharmaceutical Co., Ltd. Reveals Drop In Full Year Bottom Line

India, April 24 -- Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) revealed earnings for full year that Dropped, from the same period last year

The company's bottom line came in at RMB1.777 billion, or RMB1.93 per share. This compares with RMB2.531 billion, or RMB2.76 per share, last year.

The company's revenue for the period fell 22.4% to RMB6.218 billion from RMB8.016 billion last year.

Hubei Jumpcan Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :

-Earnings: RMB1.777 Bln. vs. RMB2.531 Bln. last year.-EPS: RMB1.93 vs. RMB2.76 last year.-Revenue: RMB6.218 Bln vs. RMB8.016 Bln last year.

For comments and feedback contact: [e-mail]

Published by HT Digital Content Services with permission from RTT News....